Literature DB >> 31246547

The Relative Importance of Race Compared to Health Care and Social Factors in Predicting Prostate Cancer Mortality: A Random Forest Approach.

Heidi A Hanson1, Christopher Martin2, Brock O'Neil1, Claire L Leiser3, Erik N Mayer2, Ken R Smith3,4, William T Lowrance2.   

Abstract

PURPOSE: There is a differential in prostate cancer mortality between black and white men. Advances in precision medicine have shifted the research focus toward underlying genetic differences. However, nonbiological factors may have a large role in these observed disparities. Therefore, we sought to measure the relative importance of race compared to health care and social factors on prostate cancer specific mortality.
MATERIALS AND METHODS: Using the SEER (Surveillance, Epidemiology, and End Results) database we identified 514,878 men diagnosed with prostate cancer at age 40 years or greater between 2004 and 2012. We also selected a subset of black and white men matched by age, stage and birth year. We stratified patients by age 40 to 54, 55 to 69 and 70 years or older and disease stage, resulting in 18 groups. By applying random forest methods with variable importance measures we analyzed 15 variables and interactions across 4 categories of factors (tumor characteristics, race, and health care and social factors) and the relative importance for prostate cancer specific mortality.
RESULTS: Tumor characteristics at diagnosis were the most important factors for prostate cancer mortality. Across all groups race was less than 5% as important as tumor characteristics and only more important than health care and social factors in 2 of the 18 groups. Although race had a significant impact, health care and social factors known to be associated with racial disparities had greater or similarly important effects across all ages and stages.
CONCLUSIONS: Eradicating disparities in prostate cancer survival will require a multipronged approach, including advances in precision medicine. Disparities will persist unless health care access and social equality are achieved among all populations.

Entities:  

Keywords:  SEER program; health services accessibility; mortality; prostatic neoplasms; race factors

Mesh:

Substances:

Year:  2019        PMID: 31246547      PMCID: PMC8276188          DOI: 10.1097/JU.0000000000000416

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

1.  Heterogeneity analysis of breast cancer families by using age at onset as a covariate.

Authors:  C Mérette; M C King; J Ott
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

2.  Trends in prostate cancer mortality among black men and white men in the United States.

Authors:  Kenneth C Chu; Robert E Tarone; Harold P Freeman
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

3.  Genetic Hitchhiking and Population Bottlenecks Contribute to Prostate Cancer Disparities in Men of African Descent.

Authors:  Sarah A Tishkoff; Timothy R Rebbeck; Joseph Lachance; Ali J Berens; Matthew E B Hansen; Andrew K Teng
Journal:  Cancer Res       Date:  2018-02-08       Impact factor: 12.701

Review 4.  Random forests for genomic data analysis.

Authors:  Xi Chen; Hemant Ishwaran
Journal:  Genomics       Date:  2012-04-21       Impact factor: 5.736

5.  Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

Authors:  B F Hankey; E J Feuer; L X Clegg; R B Hayes; J M Legler; P C Prorok; L A Ries; R M Merrill; R S Kaplan
Journal:  J Natl Cancer Inst       Date:  1999-06-16       Impact factor: 13.506

6.  Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer.

Authors:  Brandon Bernard; Vinayak Muralidhar; Yu-Hui Chen; Srikala S Sridhar; Edith P Mitchell; Curtis A Pettaway; Michael A Carducci; Paul L Nguyen; Christopher J Sweeney
Journal:  Cancer       Date:  2017-01-05       Impact factor: 6.860

7.  Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12.

Authors:  S Vijayakumar; K Winter; W Sause; M J Gallagher; J Michalski; M Roach; A Porter; M Bondy
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

8.  African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?

Authors:  Debasish Sundi; Ashley E Ross; Elizabeth B Humphreys; Misop Han; Alan W Partin; H Ballentine Carter; Edward M Schaeffer
Journal:  J Clin Oncol       Date:  2013-06-17       Impact factor: 44.544

9.  Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Authors:  Robert T Dess; Holly E Hartman; Brandon A Mahal; Payal D Soni; William C Jackson; Matthew R Cooperberg; Christopher L Amling; William J Aronson; Christopher J Kane; Martha K Terris; Zachary S Zumsteg; Santino Butler; Joseph R Osborne; Todd M Morgan; Rohit Mehra; Simpa S Salami; Amar U Kishan; Chenyang Wang; Edward M Schaeffer; Mack Roach; Thomas M Pisansky; William U Shipley; Stephen J Freedland; Howard M Sandler; Susan Halabi; Felix Y Feng; James J Dignam; Paul L Nguyen; Matthew J Schipper; Daniel E Spratt
Journal:  JAMA Oncol       Date:  2019-07-01       Impact factor: 31.777

10.  Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH database.

Authors:  Mary M Everist; Lauren E Howard; William J Aronson; Christopher J Kane; Christopher L Amling; Matthew R Cooperberg; Martha K Terris; Stephen J Freedland
Journal:  Urol Oncol       Date:  2018-12-28       Impact factor: 2.954

View more
  9 in total

1.  Factors associated with appropriate and low-value PSA testing.

Authors:  Nathaniel Oswald; Tengda Lin; Benjamin Haaland; Michael Flynn; Kensaku Kawamoto; Kathleen A Cooney; William Lowrance; Heidi A Hanson; Brock O'Neil
Journal:  Cancer Epidemiol       Date:  2020-05-08       Impact factor: 2.984

Review 2.  Artificial Intelligence Applications in Urology: Reporting Standards to Achieve Fluency for Urologists.

Authors:  Andrew B Chen; Taseen Haque; Sidney Roberts; Sirisha Rambhatla; Giovanni Cacciamani; Prokar Dasgupta; Andrew J Hung
Journal:  Urol Clin North Am       Date:  2021-10-23       Impact factor: 2.766

3.  Classify multicategory outcome in patients with lung adenocarcinoma using clinical, transcriptomic and clinico-transcriptomic data: machine learning versus multinomial models.

Authors:  Fei Deng; Lanlan Shen; He Wang; Lanjing Zhang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 4.  The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine.

Authors:  Deyana D Lewis; Cheryl D Cropp
Journal:  Genes (Basel)       Date:  2020-12-08       Impact factor: 4.096

5.  Association of Race, Ethnicity, and Socioeconomic Status With Esthesioneuroblastoma Presentation, Treatment, and Survival.

Authors:  Rahul K Sharma; Alexandria L Irace; Jonathan B Overdevest; Justin H Turner; Zara M Patel; David A Gudis
Journal:  OTO Open       Date:  2022-02-09

6.  Variation in and Factors Associated With US County-Level Cancer Mortality, 2008-2019.

Authors:  Weichuan Dong; Wyatt P Bensken; Uriel Kim; Johnie Rose; Qinjin Fan; Nicholas K Schiltz; Nathan A Berger; Siran M Koroukian
Journal:  JAMA Netw Open       Date:  2022-09-01

7.  Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults.

Authors:  Abhishek Kumar; Vinit Nalawade; Paul Riviere; Reith R Sarkar; J Kellog Parsons; James D Murphy; Brent S Rose
Journal:  JAMA Netw Open       Date:  2019-10-02

Review 8.  A scoping review on the use of machine learning in research on social determinants of health: Trends and research prospects.

Authors:  Shiho Kino; Yu-Tien Hsu; Koichiro Shiba; Yung-Shin Chien; Carol Mita; Ichiro Kawachi; Adel Daoud
Journal:  SSM Popul Health       Date:  2021-06-05

9.  Dr. Answer AI for Prostate Cancer: Predicting Biochemical Recurrence Following Radical Prostatectomy.

Authors:  Jihwan Park; Mi Jung Rho; Hyong Woo Moon; Jaewon Kim; Chanjung Lee; Dongbum Kim; Choung-Soo Kim; Seong Soo Jeon; Minyong Kang; Ji Youl Lee
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.